| Literature DB >> 34799698 |
Jakob Vowinckel1,2, Johannes Hartl1,3, Hans Marx4, Martin Kerick5,6, Kathrin Runggatscher1, Markus A Keller1,7, Michael Mülleder1,3,8, Jason Day9, Manuela Weber10, Mark Rinnerthaler10, Jason S L Yu8, Simran Kaur Aulakh8, Andrea Lehmann3, Diethard Mattanovich4, Bernd Timmermann5, Nianshu Zhang1, Cory D Dunn11,12, James I MacRae13, Michael Breitenbach10, Markus Ralser14,15,16.
Abstract
Eukaryotic cells can survive the loss of their mitochondrial genome, but consequently suffer from severe growth defects. 'Petite yeasts', characterized by mitochondrial genome loss, are instrumental for studying mitochondrial function and physiology. However, the molecular cause of their reduced growth rate remains an open question. Here we show that petite cells suffer from an insufficient capacity to synthesize glutamate, glutamine, leucine and arginine, negatively impacting their growth. Using a combination of molecular genetics and omics approaches, we demonstrate the evolution of fast growth overcomes these amino acid deficiencies, by alleviating a perturbation in mitochondrial iron metabolism and by restoring a defect in the mitochondrial tricarboxylic acid cycle, caused by aconitase inhibition. Our results hence explain the slow growth of mitochondrial genome-deficient cells with a partial auxotrophy in four amino acids that results from distorted iron metabolism and an inhibited tricarboxylic acid cycle.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34799698 PMCID: PMC7612105 DOI: 10.1038/s42255-021-00477-6
Source DB: PubMed Journal: Nat Metab ISSN: 2522-5812